AUGMENTIN

Product NDC
72508-006
Requested package NDC
72508-006-14
11-digit product format
725080006
Labeler code
72508
Product ID
72508-006_fff71910-9217-475a-af12-5e4ef4b11a60
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
amoxicillin and clavulanate potassium
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Neopharma Inc
Application
NDA050564
Marketing category
NDA
Marketing start
2019-03-01
Marketing end
0000-00-00
Substance
AMOXICILLIN; CLAVULANATE POTASSIUM
Active strength
500 mg/1; mg/1
Pharmacologic classes
Penicillin-class Antibacterial [EPC],Penicillins [CS],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage72508-00672508-006-14DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N050564-001AUGMENTIN '250'AMOXICILLIN; CLAVULANATE POTASSIUM250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06
N050564-002AUGMENTIN '500'AMOXICILLIN; CLAVULANATE POTASSIUM500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-0684e616aacf4f…
2026-09-14 22:38:342026-08N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-0684e616aacf4f…
2026-08-18 06:07:402026-07N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06caaa826d4ba7…
2026-08-18 06:07:402026-07N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06011fe1cb6892…
2026-02-19 14:30 UTC2026-02N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-0631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-0631067a03dcf5…
2025-08-23 18:47 UTC2025-08N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-066a471c1ec25d…
2025-08-23 18:47 UTC2025-08N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-066a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-0603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-0603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-062680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-062680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-065bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-065bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06d06236e962d9…
2024-10-29 15:01 UTC2024-10N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-0679d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-0679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-06301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-061e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-061e350fbaab3a…
2024-05-31 18:47 UTC2024-05N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-068072bd15b7f6…
2024-05-31 18:47 UTC2024-05N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-068072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-065c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD1984-08-065c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N050564-001AUGMENTIN '250'250MG;EQ 125MG BASETABLET / ORALRLD1984-08-065d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N050564-002AUGMENTIN '500'500MG;EQ 125MG BASETABLET / ORALRLD1984-08-065d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N050564-001AUGMENTIN '250'250MG;EQ 125MG BASETABLET / ORALRLD1984-08-064b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N050564-002AUGMENTIN '500'500MG;EQ 125MG BASETABLET / ORALRLD1984-08-064b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N050564-001AUGMENTIN '250'250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD1984-08-0674a2ff9319b5…
2019-12-13 00:20 UTC2019-12N050564-002AUGMENTIN '500'500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD1984-08-0674a2ff9319b5…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
72508-006-142021-08-10These highlights do not include all the information needed to use AUGMENTIN safely and effectively. See full prescribing information for AUGMENTIN. AUGMENTIN®(amoxicillin/clavulanate potassium) Tablets, Powder for Oral Suspension, and Chewable Tablets Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat infections that are proven or strongly suspected to be caused by
72508-006-782021-08-10These highlights do not include all the information needed to use AUGMENTIN safely and effectively. See full prescribing information for AUGMENTIN. AUGMENTIN®(amoxicillin/clavulanate potassium) Tablets, Powder for Oral Suspension, and Chewable Tablets Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat infections that are proven or strongly suspected to be caused by
72508-006-142021-07-23These highlights do not include all the information needed to use AUGMENTIN safely and effectively. See full prescribing information for AUGMENTIN. AUGMENTIN®(amoxicillin/clavulanate potassium) Tablets, Powder for Oral Suspension, and Chewable Tablets Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat infections that are proven or strongly suspected to be caused by
72508-006-782021-07-23These highlights do not include all the information needed to use AUGMENTIN safely and effectively. See full prescribing information for AUGMENTIN. AUGMENTIN®(amoxicillin/clavulanate potassium) Tablets, Powder for Oral Suspension, and Chewable Tablets Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat infections that are proven or strongly suspected to be caused by

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
72508-006-147250800061420 TABLET, FILM COATED in 1 BOTTLE (72508-006-14) 2019-03-010000-00-00NoNoCurrent